SM-102 and Lipid Nanoparticles: Predictive Modeling for E...

2025-09-19

Explore how SM-102, a cationic lipid, advances lipid nanoparticle (LNP) technology for mRNA delivery and vaccine development. This article highlights predictive modeling approaches and comparative insights from recent studies to guide R&D in optimizing LNP formulations.

DL-Lysine

2025-09-19

SM-102 and the Structure–Function Landscape in mRNA LNPs

2025-09-18

This article explores the structural and functional properties of SM-102 in lipid nanoparticles (LNPs) for mRNA delivery, emphasizing its molecular mechanisms and comparative performance in vaccine development. Recent computational and experimental insights into SM-102’s role in mRNA vaccine formulation are discussed.

DG051

2025-09-18

Anti-SOX9 Rabbit Monoclonal Antibody

2025-09-17

PhiKan 083

2025-09-17

Recombinant Mouse IL-2

2025-09-16

Aristolochic Acid A

2025-09-15

Phosphatase Inhibitor Cocktail (1 Tube, EDTA-Free,

2025-09-15

Anti-A1BG Rabbit Polyclonal Antibody

2025-09-13

6H05

2025-09-13

Salinazid

2025-09-12

6-Chloropurine

2025-09-12

Recombinant Mouse Adiponectin

2025-09-11

Recombinant Rat IL-10

2025-09-10